Q: What is Berinert used for?

Berinert is used to treat hereditary angioedema .

Q: How does Berinert work?

Restoring Protein Levels Hereditary angioedema (HAE) is a genetic condition caused by a deficiency or dysfunction of a protein called C1 esterase inhibitor. This protein plays a critical role in regulating several systems in the body that control inflammation and fluid balance. Blocking the Cause of Swelling When C1 esterase inhibitor levels are too low, certain enzymes in the blood become overactive. This leads to the excessive production of a peptide called bradykinin. Bradykinin causes blood vessels to dilate and leak fluid into the surrounding tissues, which results in the severe swelling, pain, and inflammation seen during an HAE attack. Berinert is a concentrate of human C1 esterase inhibitor. It works by: Replacing the missing protein in the bloodstream. Inhibiting the enzymes responsible for producing bradykinin. Regulating the body's inflammatory response to stop the progression of an attack. By restoring the balance of these proteins, Berinert helps reduce the fluid leakage from blood vessels and eases the symptoms of an acute attack in the abdomen, face, or throat.

Q: What are the active ingredients in Berinert?

The active ingredient in Berinert is C1 esterase inhibitor .

Q: What are the side effects of Berinert?

Common side effects of Berinert may include: headache abdominal pain nausea and others Always consult with a healthcare professional about potential side effects.

Q: What drug class is Berinert?

Berinert belongs to the C1 esterase inhibitor drug class.

Q: What is the dosage of Berinert and how do I take it?

Administration Method Berinert is administered as an injection into a vein (intravenously). It is intended for the treatment of acute abdominal, facial, or laryngeal attacks of hereditary angioedema (HAE). It should be administered as soon as symptoms of an attack are recognized. Preparation and Use The medication comes as a powder that must be mixed with sterile water before use. Once the powder is dissolved, the solution should be clear and colorless. It should not be used if the solution is cloudy or contains particles. After mixing, the medication should be administered by slow intravenous injection. Self-Administration Patients or caregivers may be able to administer Berinert at home. This requires specific training from a healthcare provider on how to prepare the medication and perform the injection. It is important to follow all instructions provided by a doctor or the manufacturer guide. If the medication is being used to treat a laryngeal (throat) attack, patients should seek immediate medical attention after administration, as these attacks can be life-threatening. Storage and Handling Berinert should be stored at room temperature or in the refrigerator, but it must not be frozen. The medication should be protected from light. Once the powder has been mixed with the diluent, the solution should be used promptly or within the timeframe specified by the manufacturer.

Q: Is Berinert safe during pregnancy and breastfeeding?

Pregnancy It is currently unknown whether Berinert can cause harm to an unborn baby or affect a person's ability to become pregnant. Clinical studies in pregnant women have not been conducted, and animal reproduction studies are also unavailable. Because of this lack of data, Berinert should be used during pregnancy only if a healthcare provider determines it is clearly needed. Breastfeeding It is not known if Berinert passes into human breast milk or if it could affect a nursing infant. If you are breastfeeding or planning to breastfeed, you should discuss the potential risks and benefits with your healthcare provider before using this medication to determine the best course of action for you and your baby.

Q: What forms and strengths does Berinert come in?

Dosage Forms Berinert is supplied as a sterile, lyophilized (freeze-dried) powder for reconstitution. It is intended for intravenous administration only and is not for subcutaneous use. Available Strengths Berinert is available in a single-use vial containing 500 International Units (IU) of C1 esterase inhibitor (human). It is typically provided in a kit that includes the following components: One vial of Berinert powder One vial of Sterile Water for Injection (diluent) A Mix2Vial transfer device Administration supplies, such as a filter and syringe The powder must be reconstituted with the provided diluent before it is injected. Because it does not contain preservatives, the medication should be used immediately after mixing.

Q: What is the FDA approval status of Berinert?

FDA Approval Status Berinert is a C1 esterase inhibitor (human) that is FDA-approved for the treatment of acute abdominal, facial, or laryngeal attacks of hereditary angioedema (HAE). It was initially approved by the FDA in 2009 for use in adults and adolescents, and its indication was later expanded to include pediatric patients of all ages. Regulatory Requirements There are currently no Boxed Warnings or Risk Evaluation and Mitigation Strategy (REMS) requirements for Berinert. However, the FDA monitors the product for safety concerns common to plasma-derived therapies and C1 esterase inhibitors, including: Hypersensitivity: Severe allergic reactions, including anaphylaxis, have been reported. Thromboembolic Events: There is a risk of blood clots associated with the administration of C1 esterase inhibitor products, particularly at high doses or in patients with existing risk factors. Infectious Agents: Because Berinert is made from human blood, it carries a theoretical risk of transmitting infectious agents, such as viruses, despite screening and inactivation steps during manufacturing.

Question 1

What is Berinert?

Accepted Answer

Berinert is a concentrated form of C1 esterase inhibitor, a protein naturally found in human blood. This protein plays a critical role in controlling the body's inflammatory response and preventing excessive swelling.

By restoring the levels of this protein, the medication helps regulate biological pathways that would otherwise cause fluid to leak from blood vessels into surrounding tissues. It is designed to supplement the body's natural defenses against abnormal inflammatory reactions.

Question 2

What is Berinert used for?

Accepted Answer

Berinert is used to treat hereditary angioedema.

Question 3

How does Berinert work?

Accepted Answer

Restoring Protein Levels

Hereditary angioedema (HAE) is a genetic condition caused by a deficiency or dysfunction of a protein called C1 esterase inhibitor. This protein plays a critical role in regulating several systems in the body that control inflammation and fluid balance.

Blocking the Cause of Swelling

When C1 esterase inhibitor levels are too low, certain enzymes in the blood become overactive. This leads to the excessive production of a peptide called bradykinin. Bradykinin causes blood vessels to dilate and leak fluid into the surrounding tissues, which results in the severe swelling, pain, and inflammation seen during an HAE attack.

Berinert is a concentrate of human C1 esterase inhibitor. It works by:

Replacing the missing protein in the bloodstream.
Inhibiting the enzymes responsible for producing bradykinin.
Regulating the body's inflammatory response to stop the progression of an attack.

By restoring the balance of these proteins, Berinert helps reduce the fluid leakage from blood vessels and eases the symptoms of an acute attack in the abdomen, face, or throat.

Question 4

What are the active ingredients in Berinert?

Accepted Answer

The active ingredient in Berinert is C1 esterase inhibitor.

Question 5

What are the side effects of Berinert?

Accepted Answer

Common side effects of Berinert may include:

headache
abdominal pain
nausea
and others

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Berinert?

Accepted Answer

Berinert belongs to the C1 esterase inhibitor drug class.

Question 7

What is the dosage of Berinert and how do I take it?

Accepted Answer

Administration Method

Berinert is administered as an injection into a vein (intravenously). It is intended for the treatment of acute abdominal, facial, or laryngeal attacks of hereditary angioedema (HAE). It should be administered as soon as symptoms of an attack are recognized.

Preparation and Use

The medication comes as a powder that must be mixed with sterile water before use. Once the powder is dissolved, the solution should be clear and colorless. It should not be used if the solution is cloudy or contains particles. After mixing, the medication should be administered by slow intravenous injection.

Self-Administration

Patients or caregivers may be able to administer Berinert at home. This requires specific training from a healthcare provider on how to prepare the medication and perform the injection. It is important to follow all instructions provided by a doctor or the manufacturer guide. If the medication is being used to treat a laryngeal (throat) attack, patients should seek immediate medical attention after administration, as these attacks can be life-threatening.

Storage and Handling

Berinert should be stored at room temperature or in the refrigerator, but it must not be frozen. The medication should be protected from light. Once the powder has been mixed with the diluent, the solution should be used promptly or within the timeframe specified by the manufacturer.

Question 8

Is Berinert safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

It is currently unknown whether Berinert can cause harm to an unborn baby or affect a person's ability to become pregnant. Clinical studies in pregnant women have not been conducted, and animal reproduction studies are also unavailable. Because of this lack of data, Berinert should be used during pregnancy only if a healthcare provider determines it is clearly needed.

Breastfeeding

It is not known if Berinert passes into human breast milk or if it could affect a nursing infant. If you are breastfeeding or planning to breastfeed, you should discuss the potential risks and benefits with your healthcare provider before using this medication to determine the best course of action for you and your baby.

Question 9

What forms and strengths does Berinert come in?

Accepted Answer

Dosage Forms

Berinert is supplied as a sterile, lyophilized (freeze-dried) powder for reconstitution. It is intended for intravenous administration only and is not for subcutaneous use.

Available Strengths

Berinert is available in a single-use vial containing 500 International Units (IU) of C1 esterase inhibitor (human). It is typically provided in a kit that includes the following components:

One vial of Berinert powder
One vial of Sterile Water for Injection (diluent)
A Mix2Vial transfer device
Administration supplies, such as a filter and syringe

The powder must be reconstituted with the provided diluent before it is injected. Because it does not contain preservatives, the medication should be used immediately after mixing.

Question 10

What is the FDA approval status of Berinert?

Accepted Answer

FDA Approval Status

Berinert is a C1 esterase inhibitor (human) that is FDA-approved for the treatment of acute abdominal, facial, or laryngeal attacks of hereditary angioedema (HAE). It was initially approved by the FDA in 2009 for use in adults and adolescents, and its indication was later expanded to include pediatric patients of all ages.

Regulatory Requirements

There are currently no Boxed Warnings or Risk Evaluation and Mitigation Strategy (REMS) requirements for Berinert. However, the FDA monitors the product for safety concerns common to plasma-derived therapies and C1 esterase inhibitors, including:

Hypersensitivity: Severe allergic reactions, including anaphylaxis, have been reported.
Thromboembolic Events: There is a risk of blood clots associated with the administration of C1 esterase inhibitor products, particularly at high doses or in patients with existing risk factors.
Infectious Agents: Because Berinert is made from human blood, it carries a theoretical risk of transmitting infectious agents, such as viruses, despite screening and inactivation steps during manufacturing.

Question 11

What should I know about Berinert and cost?

Accepted Answer

Factors Affecting Price

Berinert is a specialty biologic medication, and its cost is influenced by several variables:

Weight-Based Dosing: The standard dose is 20 International Units (IU) per kilogram of body weight. Patients with higher body weights require more medication, which increases the cost per treatment.
Insurance and Prior Authorization: Most insurance plans require prior authorization before they will cover Berinert. The specific out-of-pocket cost depends on the individual's pharmacy or medical benefit structure, including deductibles and coinsurance.
Site of Care: Costs may differ depending on whether the medication is self-administered at home or administered by a healthcare professional in a clinical setting, which may incur additional service fees.

Financial Support Options

To help manage the cost of treatment for hereditary angioedema, financial assistance may be available:

Manufacturer Support: The manufacturer often provides patient support services that can help navigate insurance approvals and identify financial aid options.
Copay Assistance: Patients with commercial insurance may qualify for copay cards to lower their out-of-pocket expenses.
Patient Assistance Programs: There may be programs available for patients who are uninsured or underinsured to help them access the medication at a lower cost.

Berinert

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

Found an Error?

Find Discounts for Berinert

Hospitals.net Disclosure